Pasar al contenido principal

NUEVAS APROXIMACIONES TERANOSTICAS EN HIPERTENSION PULMONAR: INTERVENCIONES EN EL ESTILO DE VIDA

PID2021-123238OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario ASOCIACIÓN CENTRO DE INVESTIGACION COOP. BIOMATERIALES

Resultados relacionados

Resultados totales (Incluyendo duplicados): 12
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

Pulmonary surfactant nanoparticles for lung‐targeted and dose‐efficient delivery

  • Fernández Méndez, Laura
  • Piñol Cancer, Marina
  • Souto Riobó, Itziar
  • Urkola Arsuaga, Ainhize
  • González Lozano, Elena
  • Fernández Folgueral, Irene
  • de Alejo, Claudia Miranda Pérez
  • Azkargorta, Mikel
  • Elortza, Felix
  • Tagliaferro Quiñonero, Alberto
  • Silvio, Desire Di
  • Cañadas Benito, Olga
  • Maiz, Jon
  • Pérez Gil, Jesús
  • Ramos Cabrer, Pedro
  • Ruíz Cabello, Jesús
  • Carregal Romero, Susana
Although pulmonary drug delivery enables lung-targeted therapy, its clinical efficacy is often limited by inflammation, heterogeneous deposition, and physiological barriers such as mucociliary clearance and phagocytic uptake. Here, we report a biomimetic platform based on pulmonary surfactant nanoparticles (PSNPs) that preserves native surfactant proteins and biophysical functionality, resulting in enhanced pulmonary delivery. Microfluidic synthesis yielded highly uniform PSNPs with improved encapsulation efficiency and colloidal stability, while markedly increasing surfactant protein retention from 33% using conventional extrusion to 95% via microfluidics, corresponding to a 2.4-fold improvement. Functionally, PSNPs exhibited superior interfacial activity compared to lipid-only liposomes, increasing surface pressure from 5–10 mN/m to 25–30 mN/m, and achieved an approximately 80-fold enhancement in alveolar cellular uptake. In vitro, nintedanib-loaded PSNPs significantly reduced fibroblast migration, proliferation, collagen deposition, and TGF-β secretion relative to free drug and control formulations. In vivo, PSNPs demonstrated high pulmonary retention (95% injected dose per gram of lung tissue), efficient penetration into fibrotic regions, and minimal off-target accumulation in the liver (0.5%). Therapeutic efficacy was confirmed in a bleomycin-induced pulmonary fibrosis model, where PSNPs improved lung function and restored tissue architecture at doses as low as 0.5 mg/kg. Collectively, these results establish PSNPs as a robust lung-targeted nanotherapeutic platform, where microfluidic synthesis enables enhanced biomimicry, improved protein preservation, and superior therapeutic performance compared to conventional fabrication methods.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Benchtop NMR urine metabolomics for diagnosing pulmonary tuberculosis

  • Comella-del-Barrio, Patricia|||0000-0002-2433-9864
  • Rodríguez, Ignacio
  • Bimba, John|||0000-0001-7847-4271
  • Osazuwa, Okoedoh
  • Alaran, Ramota
  • Alonso, Pilar
  • Blasco Iturri, Zuriñe
  • Miguel-Coello, Ana B
  • Cuevas, Luis E.|||0000-0002-6581-0587
  • Ruiz-Cabello, Jesús|||0000-0001-8681-5056
  • Izquierdo-Garcia, José Luis
  • Domínguez, José|||0000-0001-7888-0309
Tuberculosis (TB) remains a major global health issue, especially in resource-limited settings, where rapid and accurate diagnosis is critical yet often lacking. Nuclear magnetic resonance (NMR)-based metabolomics has emerged as a promising tool for identifying disease-specific biomarkers. This study assessed the diagnostic potential of urinary metabolomics using high-resolution (HR-)NMR and benchtop NMR (bNMR) in Nigerian adults with presumed pulmonary TB, including individuals with and without HIV. Urine samples were analysed by HR-NMR and bNMR. Multivariate analysis was used to develop classification models based on confirmed TB status. Key discriminant metabolites were identified. In HIV-negative individuals, HR-NMR achieved 84% sensitivity and 86% specificity, while bNMR reached 83% and 84%, respectively. In people living with HIV, HR-NMR reached 75% sensitivity and 70% specificity; bNMR achieved 90% and 46%. Both models met or exceeded WHO sensitivity criteria for non-sputum-based TB diagnostics. Thirteen discriminatory metabolites were identified, with eight consistent with previous studies. These findings suggest common metabolic signatures of TB, regardless of HIV status. Urinary NMR-based metabolomics shows strong potential for TB diagnosis in high TB/HIV burden settings. HR-NMR provides excellent accuracy, while bNMR offers a cost-effective alternative. Further studies are needed to validate and optimise this approach for clinical use.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A Comparative Study of Ultrasmall Calcium Carbonate Nanoparticles for Targeting and Imaging Atherosclerotic Plaque

  • Martínez-Parra, Lydia
  • Piñol-Cancer, Marina
  • Sanchez-Cano, Carlos
  • Miguel-Coello, Ana Beatriz
  • Di Silvio, Desiré
  • Gómez, Ana M.
  • Uriel, Clara
  • Plaza-García, S.
  • Gallego, M.
  • Pazos, Raquel
  • Groult, Hugo
  • Jeannin, Marc
  • Geraki, Kalotina
  • Fernández-Méndez, Laura
  • Urkola-Arsuaga, Ainhize
  • Sánchez-Guisado, Mª Jesús
  • Carrillo-Romero, Juliana
  • Parak, Wolfgang J.
  • Prato, Maurizio
  • Herranz, Fernando
  • Ruíz-Cabello, Jesús
  • Carregal-Romero, Susana
therosclerosis is a complex disease that can lead to life-threatening events, such as myocardial infarction and ischemic stroke. Despite the severity of this disease, diagnosing plaque vulnerability remains challenging due to the lack of effective diagnostic tools. Conventional diagnostic protocols lack specificity and fail to predict the type of atherosclerotic lesion and the risk of plaque rupture. To address this issue, technologies are emerging, such as noninvasive medical imaging of atherosclerotic plaque with customized nanotechnological solutions. Modulating the biological interactions and contrast of nanoparticles in various imaging techniques, including magnetic resonance imaging, is possible through the careful design of their physicochemical properties. However, few examples of comparative studies between nanoparticles targeting different hallmarks of atherosclerosis exist to provide information about the plaque development stage. Our work demonstrates that Gd (III)-doped amorphous calcium carbonate nanoparticles are an effective tool for these comparative studies due to their high magnetic resonance contrast and physicochemical properties. In an animal model of atherosclerosis, we compare the imaging performance of three types of nanoparticles: bare amorphous calcium carbonate and those functionalized with the ligands alendronate (for micro- calcification targeting) and trimannose (for inflammation targeting). Our study provides useful insights into ligand-mediated targeted imaging of atherosclerosis through a combination of in vivo imaging, ex vivo tissue analysis, and in vitro targeting experiments., We acknowledge M. Spuch for his scientific drawings and the Basque Government for the R&D Project in Health (grant number 2022333041). S.C.R. acknowledges the Spanish Ministerio de Ciencia e Innovación (MCIN)/Agencia Estatal de Investigación (AEI) Grant PID2019-106139RA-100 funded by MCIN/AEI/10.13039/501100011033 and the Ramon y Cajal Grant RYC2020-030241-I. C.S.C. acknowledges financial support from the Spanish State Research Agency (grant PID2020-118176RJ-I100), and the Gipuzkoa Foru Aldundia (Gipuzkoa Fellows program; grant number 2019-FELL- 000018-01/62/2019). This work was performed under the Severo Ochoa Centers of Excellence Program of the Spanish State Research Agency − Grant No. CEX2018-000867-S (DIPC). SXRF analysis was carried out with the support of Diamond Light Source, beamline I18 (proposal SP27720). J.R.C. is funded by MCIN/AEI/10.13039/501100011033 (PID2021-123238OB-I00) and from La Caixa Foundation (Health Research Call 2020: HR20-00075). A.M.G. and C.U. acknowledge the Spanish Ministerio de Ciencia e Innovación (MCIN)/Agencia Estatal de Investigación (AEI) Grant: PID2021-122504NB-I00 funded by MCIN/AEI/10.13039/ 501100011033 and by “ERDF A way of making Europe. W.J.P. acknowledges funding from the Cluster of Excellence “Advanced Imaging of Matter” of the Deutsche Forschungsge- meinschaft (DFG) - EXC 2056 - project ID 390715994. F.H. acknowledges MCIN (PID2019-104059RB-I00) and M.J.S.G. the Spanish Ministerio de Educación y Formación Profesional (PRE2018-083691)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Radiolabeled Iron Oxide Nanomaterials for Multimodal Nuclear Imaging and Positive Contrast Magnetic Resonance Imaging (MRI): A Review

  • Pellico, Juan
  • Ruíz-Cabello, Jesús
  • Herranz, Fernando
Iron oxide nanoparticles (IONP) have been hailed as potential game-changers in biomedical imaging owing to their biocompatibility and size-dependent properties. One area where IONP has shown particular promise is magnetic resonance imaging (MRI), which traditionally uses superparamagnetic nanomaterials to produce negative contrast that darkens the tissues where nanoparticles accumulates. Unfortunately, this hypointense signal is a major drawback for clinical applications because it can make it difficult to identify the accumulated probes. As a result, researchers are exploring alternative options that can incorporate the advantages of IONP while also possessing valuable properties for molecular imaging. To achieve this goal, the most effective method involves not only utilizing positive contrast in MRI applications but also combining IONP with the unparalleled sensitivity of nuclear imaging techniques, for example, using radioisotopes to create PET/(T)MRI multimodal probes. To create such probes, various factors must be considered, including the radiolabeling strategy employed and overall complexity of the final nanoprobe. These nanoradiomaterials offer novel possibilities that span beyond the molecular imaging field, showing potential for the development of radiopharmaceuticals and theranostics., This study was supported by the Spanish Ministry of Science and Innovation (PID2019-104059RB-I00, PDC2022-133493- I00, PID2021-123238OB-I00), Comunidad de Madrid (S2022/BMD-7333) and La Caixa Foundation (Health Research Call 2020: HR20-00075).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Lipid-based nanomedicines for the treatment of bacterial respiratory infections: current state and new perspectives

  • Arroyo-Urea, Eva María
  • Lázaro-Díez, María
  • Garmendia, Juncal
  • Herranz, Fernando
  • González-Paredes, Ana
The global threat posed by antimicrobial resistance demands urgent action and the development of effective drugs. Lower respiratory tract infections remain the deadliest communicable disease worldwide, often challenging to treat due to the presence of bacteria that form recalcitrant biofilms. There is consensus that novel anti-infectives with reduced resistance compared with conventional antibiotics are needed, leading to extensive research on innovative antibacterial agents. This review explores the recent progress in lipid-based nanomedicines developed to counteract bacterial respiratory infections, especially those involving biofilm growth; focuses on improved drug bioavailability and targeting and highlights novel strategies to enhance treatment efficacy while emphasizing the importance of continued research in this dynamic field., This work was supported by Atracción de Talento program (Modalidad 1) from Comunidad de Madrid (Spain) (Reference 2019-T1/IND-12906), Nanomedicine CSIC Hub (Spain) funding (PIE 202180E048), Spanish Ministry of Science and Innovation (PID2021-123238OB-I00, PID2021-125947OB-I00, PDC2022-133493-I00, RED2022-134299-T), Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) (875/2019), Gobierno de Navarra (Spain) (PC150, PC136) and Comunidad de Madrid (Spain) (P2022/BMD-7333). CIBER is an initiative from Instituto de Salud Carlos III (ISCIII) (Spain). EM Arroyo-Urea benefits from the FPU fellowship program of the Spanish Ministry of Universities (reference FPU21/04116). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Periodic table screening for enhanced positive contrast in MRI and in vivo uptake in glioblastoma

  • Herraiz-Pérez, Aitor
  • Morales, María Del Puerto
  • Martínez-Parra, Lydia
  • Arias-Ramos, Nuria
  • López-Larrubia, Pilar
  • Gutiérrez, Lucía
  • Mejías, Jesús
  • Díaz-Ufano, Carlos
  • Ruíz-Cabello, Jesús
  • Herranz, Fernando
The quest for nanomaterial-based imaging probes that can provide positive contrast in MRI is fueled by the necessity of developing novel diagnostic applications with potential for clinical translation that current gold standard probes cannot provide. Although interest in nanomaterials for positive contrast has increased in recent years, their study is less developed than that of traditional negative contrast probes in MRI. In our search for new magnetic materials with enhanced features as positive contrast probes for MRI, we decided to explore the chemical space to comprehensively analyze the effects of different metals on the performance of iron oxide nanomaterials already able to provide positive contrast in MRI. To this end, we synthesized 30 different iron oxide-based nanomaterials. Thorough characterization was performed, including multivariate analysis, to study the effect of different variables on their relaxometric properties. Based on these results, we identified the best combination of metals for in vivo imaging and tested them in different experiments. First, we tested its performance on magnetic resonance angiography using a concentration ten times lower than that clinically approved for Gd. Finally, we studied the capability of these nanomaterials to cross the affected blood–brain barrier in a glioblastoma model. The results showed that the selected nanomaterials provided excellent positive contrast at large magnetic field and were able to accumulate at the tumor site, highlighting the affected tissue., This study was supported by a grant for predoctoral contracts for the training of PhD students from the Spanish Ministry of Science and Innovation (grant number PRE2020-091870), associated with the National Plan project PID2019-104059RB-100. We acknowledge funding from the Spanish Ministry of Science and Innovation (PID2021-123238OB-100, PDC2022-133493-100, RED2022-134299-T), La Caixa Foundation (Health Research Call 2020: HR20-00075), the Basque Government, R&D Projects in Health (Grant no. 2022333041) and Comunidad de Madrid (P2022/BMD-7333). Conexión Nanomedicina CSIC., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

NIR-II Photoresponsive magnetoliposomes for remote-controlled release and magnetic resonance imaging

  • Fernández-Méndez, Laura
  • Fernández-Afonso, Yilian
  • Martínez-Vicente, Pablo
  • Urkola-Arsuaga, Ainhize
  • Miranda-Pérez de Alejo, Claudia
  • Pisa, Irati L. de la
  • Plaza-García, Sandra
  • Ruíz-Cabello, Jesús
  • Ramos-Cabrer, Pedro
  • Gutiérrez, Lucía
  • Carregal-Romero, Susana
Magnetic nanoparticles, especially iron oxide nanoparticles, have become versatile and widely used tools in nanomedicine due to their unique magnetic properties, biocompatibility, and tunable functionality. Liposomes have further enhanced the potential of iron oxide nanoparticles by serving as effective nanocarriers with advantages such as drug coencapsulation and enhanced molecular imaging properties. In this study, we present magnetoliposomes composed of ultrasmall free-floating iron oxide nanoparticles inside liposomes (LP-IONPs) and thermoresponsive phospholipids, which were designed as dual T2-T1 magnetic resonance imaging (MRI) contrast agents for image-guided liposome degradation and infrared light-responsive nanocarriers in the second biological window for remote-controlled drug delivery. We demonstrated a dynamic shift from T2 to T1 MRI contrast during intracellular degradation of LP-IONPs, along with successful light-activated drug release in cancer cells. Biodistribution studies using MRI and histological analysis confirmed their potential for in vivo applications. These results highlight the potential of LP-IONPs as image-guided and remote-controlled drug delivery systems., S.C.R. thanks the MCIN/AEI 10.13039/501100011033 projects (PID2019-106139RA-100, CNS2023-143944, RYC2020-030241-I, and PID2022-142842OB-I00), the Ikerbasque (Basque Foundation for Science), and the Ramón Areces Foundation (CIVP21S13151). J.R.C. is funded by MCIN/AEI/10.13039/501100011033 (PID2021-123238OB-I00), the Basque Government through the Elkartek 2024 program (bmG24), and R&D projects in Health (grant number 2022333041). S.C.R. and J.R.C. thank IKERBASQUE for its support. L.G. thanks Project CNS2023-144321, funded by MICIU/AEI/10.13039/501100011033 and NextGenerationEU/PRT, and Fondo Social del Gobierno de Aragón (grupo DGA E15-23R). We also thank the Fundación contra la Hipertensión Pulmonar for funding (Empathy). CIBERES and CIBERBBN were co-funded by FEDER and ISCIII., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Iron Oxide Nanoparticles for Ligand-Mediated Targeted Imaging

  • Miranda-Pérez de Alejo, Claudia
  • Miguel-Coello, Ana B.
  • Piñol-Cancer, Marina
  • Urkola-Arsuaga, Ainhize
  • Martínez-Parra, Lydia
  • Carrillo-Romero, Juliana
  • Fernández-Méndez, Laura
  • Goñi-de-Cerio, Felipe
  • Herranz, Fernando
  • Silvio, Desire di
  • Gallego, Marta
  • Sierra-Serrano, Beatriz
  • Cardo, Lucia
  • Carregal-Romero, Susana
  • Ruiz-Cabello, Jesús
Superparamagnetic iron oxide nanoparticles (SPIONs) are widely employed as platforms for ligand-mediated targeting in multimodal imaging and targeted therapeutic applications owing to their intrinsic magnetic properties and versatility for surface and core modification. In addition to magnetic resonance imaging contrast, SPIONs can be labeled with radioisotopes incorporated into the crystalline structure or functionalized with chemically bound dyes or chelating agents, enabling complementary imaging modalities such as fluorescence imaging and positron emission tomography. However, chemical functionalization of nanoparticles with targeting ligands can induce alterations not only in their physicochemical properties but also in their interactions with biological systems. These nano-biointeractions are critical determinants of biological performance and must be carefully evaluated. In this study, we investigate the impact of ligand functionalization on SPION-cancer cell interactions to elucidate key parameters relevant to the successful clinical translation of nanomedicine-based targeted imaging agents., SCR acknowledges the Ramón Areces Foundation (CIVP21S13151),the MCIN/AEI 10.13039/501100011033 projects (PID2022-142842OB-I00,CNS2023-143944, RYC2020-030241-I), the Eusko Jaurlaritza projects(PIBA_2025_1_0057) and the Diputación Foral de Gipuzkoa (2025-CIE4-000041-01). JRC is funded by the MCIN/AEI/10.13039/501100011033(PID2021-123238OB-I00 and PID2024-155807OB-C21), the Eusko Jaurlar-itza under the Elkartek 2024 and 2025 Programs (KK-2024-00041, bmG24,and KK-20205-00084, TERACARD, respectively), and R&D projects in Health (Grant number 2022333041). SCR and JRC thank IKERBASQUE for their sponsorships. We also acknowledge the “Fundación contra la hipertensión pulmonar” for funding (Empathy)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

NLRP3 haploinsufficiency unmasks a compensatory NLRP1-NLRP3 interaction that drives accelerated aging in mice

  • Muela-Zarzuela, Inés
  • Alcocer-Gómez, Elisabet
  • Suarez-Rivero, Juan M.
  • Low, Evon
  • Ishaq, Abbas
  • Azkargorta, Mikel
  • Luque-Sierra, Amparo
  • Martin, Franz
  • Elortza, Félix
  • Astorga-Gamaza, Antonio
  • Antón, Rosa
  • Bali, Sofía
  • Tamargo-Azpilicueta, Joaquin
  • Guerra-Castellano, Alejandra
  • Díaz-Moreno, Irene
  • Joachimiak, Lukasz A.
  • Oroz, Javier
  • Ruiz-Cabello, Jesús
  • von Zglinicki, Thomas
  • Sanz, Alberto
  • Cordero, Mario D.
The NLRP3 inflammasome has been implicated in a wide range of human diseases, including cardiovascular, metabolic, neurodegenerative (such as Alzheimer's disease), and other age-related conditions. This has positioned NLRP3 as a promising pharmacological target. Numerous studies have shown that complete NLRP3 ablation can prevent or mitigate these diseases. However, total elimination of NLRP3 is not a feasible therapeutic strategy for the millions of patients affected by these degenerative disorders. Consequently, drug development efforts have focused on partial inhibition of NLRP3 using compounds that reduce its expression or activity. Paradoxically, although many studies have used Nlrp3 knockout mouse models, Nlrp3 haploinsufficient mice-more representative of the effects of pharmacological inhibition-are rarely included and remain poorly characterized. Here, we report the long-term effects of Nlrp3 haploinsufficiency during aging. Although no overt differences were observed in early life, by 16 months of age, Nlrp3 heterozygous mice exhibited signs of accelerated inflammatory aging, driven by compensatory overexpression of NLRP1. Mechanistic studies provide evidence of a previously unidentified interaction between NLRP1 and NLRP3, forming a hybrid inflammasome that drives NLRP1-mediated inflammatory overactivation when NLRP3 expression is reduced. Accordingly, anti-inflammatory treatment provided notable but moderate improvement of the inflammatory phenotype, whereas genetic inhibition of Nlrp1 more consistently reduced inflammation and extended health span. Our findings reveal a previously unidentified compensatory interaction between NLRP1 and NLRP3 and suggest that multiinflammasome inhibition may offer a more effective strategy for treating aging and age-related diseases., This study was supported by grant PI21/01656 from the Instituto de Salud Carlos III (Spain), grant EMC21_00033 from the EMERGIA programme of the Junta de Andalucía, and grant CNS2024-154939 from the Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación. Funding for open access publication was provided by the Universidad Pablo de Olavide/CBUA. J.R.-C . is funded by grant PID2021-123238OB- I00 and PID2024-155807OB- C 21 funded by the MCIN/AEI and from the Fundación contra la Hipertensión Pulmonar (Project Empathy). I.D.-M. is funded by grant PID2024-157414NB- I00 funded by the MICIU/AEI/10.13039/501100011033 and by ERDF/EU, Ramon Areces Foundation (LEUCYTO-FRA2025- MAR), grant FPU22/01094 funded by MICIU/AEI/10.13039/501100011033 and by ESF+ to J.T.-A., and grant PTQ2024-013941 funded by MICIU/AEI/10.13039/501100011033 to A.G.-C . J.O. is supported by the grants PID2019-109276RA- I00 and PID2022-142382OB- I00 funded by MCIN/AEI/10.13039/501100011033 and by FEDER A way to make Europe and by donations from the Spanish and Mexican Ondine Associations. J.O. was a recipient of a Leonardo Grant from the Spanish BBVA Foundation (BBM_TRA_0203) and a Ramón y Cajal Fellow of the Spanish AEI-Ministry of Science and Innovation (RYC2018-026042- I funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Periodic table screening for enhanced positive contrast in MRI and <i>in vivo</i> uptake in glioblastoma

  • Herraiz, Aitor
  • Morales, M. Puerto
  • Martínez-Parra, Lydia
  • Arias-Ramos, Nuria
  • López-Larrubia, Pilar
  • Gutiérrez, Lucía
  • Mejías, Jesús
  • Díaz-Ufano, Carlos
  • Ruiz-Cabello, Jesús
  • Herranz, Fernando
The quest for nanomaterial-based imaging probes that can provide positive contrast in MRI is fueled by the necessity of developing novel diagnostic applications with potential for clinical translation that current gold standard probes cannot provide. Although interest in nanomaterials for positive contrast has increased in recent years, their study is less developed than that of traditional negative contrast probes in MRI. In our search for new magnetic materials with enhanced features as positive contrast probes for MRI, we decided to explore the chemical space to comprehensively analyze the effects of different metals on the performance of iron oxide nanomaterials already able to provide positive contrast in MRI. To this end, we synthesized 30 different iron oxide-based nanomaterials. Thorough characterization was performed, including multivariate analysis, to study the effect of different variables on their relaxometric properties. Based on these results, we identified the best combination of metals for in vivo imaging and tested them in different experiments. First, we tested its performance on magnetic resonance angiography using a concentration ten times lower than that clinically approved for Gd. Finally, we studied the capability of these nanomaterials to cross the affected blood–brain barrier in a glioblastoma model. The results showed that the selected nanomaterials provided excellent positive contrast at large magnetic field and were able to accumulate at the tumor site, highlighting the affected tissue
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

NIR-II Photoresponsive Magnetoliposomes for Remote-Controlled Release and Magnetic Resonance Imaging

  • Fernández-Méndez, Laura
  • Fernández-Afonso, Yilian
  • Martínez-Vicente, Pablo
  • Urkola-Arsuaga, Ainhize
  • Miranda-Pérez de Alejo, Claudia
  • L. de la Pisa, Irati
  • Plaza-García, Sandra
  • Ruíz-Cabello, Jesús
  • Ramos-Cabrer, Pedro
  • Gutiérrez, Lucía
  • Carregal-Romero, Susana
Magnetic nanoparticles, especially iron oxide nano-particles, have become versatile and widely used tools in nanomedicinedue to their unique magnetic properties, biocompatibility, and tunablefunctionality. Liposomes have further enhanced the potential of ironoxide nanoparticles by serving as effective nanocarriers with advantagessuch as drug coencapsulation and enhanced molecular imagingproperties. In this study, we present magnetoliposomes composed ofultrasmall free-floating iron oxide nanoparticles inside liposomes (LP-IONPs) and thermoresponsive phospholipids, which were designed asdual T2-T1 magnetic resonance imaging (MRI) contrast agents forimage-guided liposome degradation and infrared light-responsivenanocarriers in the second biological window for remote-controlleddrug delivery. We demonstrated a dynamic shift from T2 to T1 MRIcontrast during intracellular degradation of LP-IONPs, along with successful light-activated drug release in cancer cells.Biodistribution studies using MRI and histological analysis confirmed their potential for in vivo applications. These results highlightthe potential of LP-IONPs as image-guided and remote-controlled drug delivery systems.
Docta Complutense
Publicación Artículo científico (JournalArticle)

The role of PEGylation in the pulmonary delivery of antifibrotic liposomal therapies

  • Piñol Cancer, Marina
  • Fernández Méndez, Laura
  • Carrillo Romero, Juliana
  • Urkola Arsuaga, Ainhize
  • Azkargorta, Mikel
  • Elortza, Félix
  • Goñi de Cerio, Felipe
  • García Mouton, Cristina
  • Miranda-Pérez de Alejo, Claudia
  • Ismalaj, Ermal
  • Cañadas Benito, Olga
  • Pérez Gil, Jesús
  • Ruiz-Cabello Osuna, Jesús
  • Carregal Romero, Susana
PEGylation is commonly used to improve the pharmacokinetics and efficacy of intravenously administered drug nanocarriers; however its impact on pulmonary drug delivery remains unclear. While previous studies have focused on its role in crossing the lung mucosal barrier and stabilizing formulations for nebulization, less is known about its effects on lung surfactant corona composition, biodistribution, and therapeutic efficacy. Here, we present a multiscale study on how PEG-free and PEGylated liposomes loaded with pirfenidone interact with pulmonary barriers. PEGylation increased mucus penetration and reduced protein adsorption in the lung surfactant corona. However, statistical analysis of functional proteins showed only moderate changes in anti-inflammatory and adhesion proteins, with no apparent effect on key surfactant proteins that influence liposome fate in the lung. This correlated with similar biodistributions and retention times in both healthy and fibrotic lungs for PEG-free and PEGylated liposomes. Concerningly, PEGylated liposomes enhanced native surfactant fluidity, potentially altering lung function. In a bleomycin-induced pulmonary fibrosis model, both PEG-free and PEGylated liposomes improved the antifibrotic efficacy of pirfenidone. However, PEGylation attenuated the reduction in fibrotic biomarkers within the lung fluid. These findings suggest that, although PEGylation facilitates mucus penetration, it does not significantly enhance therapeutic outcomes and may adversely affect lung function. This study provides critical insights into the optimization of lipid-based nanocarriers for pulmonary fibrosis and other lung diseases.